Novavax (NVAX) Gross Margin Growth (3y) (2014 - 2026)
Powered by 
Analysis
Novavax (NVAX) Gross Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 14,836.00 |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 589.00 |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 53.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 569.00 |
| 10 | Novavax | 1.67 Bn | 951.85 Mn | 42.45 Mn | -1,198.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,198.00 |
| Mar 31, 2026 | 2,011.00 |
| Dec 31, 2025 | 3,584.00 |
| Sep 30, 2025 | 2,865.00 |
| Jun 30, 2025 | 13,939.00 |
| Mar 31, 2025 | 4.00 |
| Dec 31, 2024 | -4,152.00 |
| Sep 30, 2024 | -7,173.00 |
| Jun 30, 2024 | -1,113.00 |
| Mar 31, 2024 | -6,309.00 |
| Sep 30, 2015 | 2,447.00 |
| Jun 30, 2015 | 5,286.00 |
| Mar 31, 2015 | 5,666.00 |
| Jun 30, 2014 | -2,076.00 |
| Mar 31, 2014 | 64.00 |